Clinical Research Directory
Browse clinical research sites, groups, and studies.
Use of Shock Wave Therapy for Neo-Vascularisation in Non-critical Coronary Artery Disease: Validation by Quantitative Cardiac MRI Perfusion
Sponsor: The University of Hong Kong
Summary
This is a randomised controlled trial aimed to demonstrate the effect of cardiac extracorporeal shock wave therapy (CSWT) on the angiogenesis effect of myocardium by determining myocardial perfusion and left ventricular function in patients with coronary artery disease (CAD) when measured by cardiac MRI before and after the treatment.
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2020-09-01
Completion Date
2026-01-01
Last Updated
2025-07-16
Healthy Volunteers
No
Conditions
Interventions
Extracorporeal shock wave therapy
Extracorporeal shock wave therapy (ESWT) delivers acoustic energy transmitted through liquid medium to internal body tissues. The intervention group will receive a total of 9 ESWT treatment sessions and 200 shocks will be applied to each ischaemic zone of myocardium for 3 times a week on the three weeks that the patients receive ESWT.
Locations (1)
HKU Li Ka Shing Faculty of Medicine
Hong Kong, Hong Kong